<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65295">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01707238</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-39</org_study_id>
    <nct_id>NCT01707238</nct_id>
  </id_info>
  <brief_title>Multi-Centre Clinical Evaluation Of Two Daily Disposable Contact Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The stenfilcon A daily disposable contact lens will provide non-inferior handling compared
      to etafilcon A daily disposable contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)</study_design>
  <primary_outcome>
    <measure>Lens handling</measure>
    <time_frame>after 2 weeks of lens wear</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>etafilcon A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>stenfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>stenfilcon A</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A; stenfilcon A</intervention_name>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_label>stenfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stenfilcon A; etafilcon A</intervention_name>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_label>stenfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:-

          -  Be between 16 and 45 years of age (inclusive)

          -  Adapted soft CL wearers (i.e. &gt; 1 month)

          -  Spherical distance CL prescription between -1.00 and -6.00D (inclusive)

          -  Spectacle cylinder ≤0.75D in the least astigmatic eye, ≤1.00D in the other.

          -  Correctable to 6/9 (20/30) in both eyes

          -  Have the use of a mobile phone to send and receive text messages throughout the day
             for the duration of the study.

          -  Have read, understood and signed the informed consent

          -  Willing to comply with the wear schedule (at least 40 hours per week)

          -  Willing to comply with the study visit schedule

        Exclusion Criteria:-

          -  Any active corneal infection, injury or inflammation

          -  Systemic or ocular allergies, which might interfere with CL wear

          -  Systemic disease, which might interfere with CL wear

          -  Ocular disease, which might interfere with CL wear

          -  Strabismus, amblyopia

          -  Subjects who have undergone corneal refractive surgery and any anterior segment
             surgery

          -  Subjects with keratoconus or other severe corneal irregularity contraindicating lens
             wear

          -  Pregnant or lactating

          -  Use of systemic/topical medication contraindicating CL wear

          -  Use of gas permeable contact lenses within the last month

          -  Employees of the investigational site or immediate family members of Investigators

          -  Participation in any concurrent clinical trial or in the last 30 days
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Keith Tempany Opticians</name>
      <address>
        <city>Broadstone</city>
        <state>Dorset</state>
        <zip>MH18</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cameron-Davies Optometrists</name>
      <address>
        <city>Southsea</city>
        <state>Hampshire</state>
        <zip>PO5 2AT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cameron-Davies Optometrists</name>
      <address>
        <city>Portchester</city>
        <state>Hants</state>
        <zip>PO16 9UN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leightons Opticians</name>
      <address>
        <city>St. Albans</city>
        <state>Hertfordshire</state>
        <zip>AL1 3LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>David Gould Opticians</name>
      <address>
        <city>Rawtenstall</city>
        <state>Lancashire</state>
        <zip>BB4 7QN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vision Express Optical Lab</name>
      <address>
        <city>Hendon</city>
        <state>London</state>
        <zip>NW4 3FB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>S.H. Harrold</name>
      <address>
        <city>Uxbridge</city>
        <state>London</state>
        <zip>UB8 1JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 17, 2013</lastchanged_date>
  <firstreceived_date>September 21, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
